{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:12:31Z","timestamp":1791825151194,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.autrev.2011.07.005","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T12:53:47Z","timestamp":1311684827000},"page":"48-55","source":"Crossref","is-referenced-by-count":149,"title":["Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature"],"prefix":"10.1016","volume":"11","author":[{"given":"C.","family":"Ferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Scaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Zignego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.07.005_bb0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.07.005_bb0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.07.005_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0020","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood.V82.12.3701.3701","article-title":"Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia","volume":"82","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.07.005_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.07.005_bb0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0035","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.07.005_bb0040","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/S1590-8658(07)80020-X","article-title":"Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia","volume":"39","author":"Mazzaro","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0045","first-page":"1157","article-title":"Rituximab for the treatment of type II mixed cryoglobulinemia","volume":"84","author":"Zaja","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2011.07.005_bb0050","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/ard.61.10.922","article-title":"Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)","volume":"61","author":"Arzoo","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0055","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/art.10345","article-title":"Rituximab for the treatment of type II mixed cryoglobulinemia","volume":"46","author":"Zaja","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.07.005_bb0060","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.07.005_bb0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/pr.109.002006","article-title":"Therapeutic targeting of B cells for rheumatic autoimmune diseases","volume":"63","author":"Engel","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.01.002","article-title":"The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE","author":"Wang","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.04.013","article-title":"B cells in systemic sclerosis: a possible target for therapy","author":"Bosello","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2796.2009.02207.x","article-title":"CD20-depleting therapy in autoimmune diseases: from basic research to the clinic","volume":"167","author":"Perosa","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2011.07.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.04.030","article-title":"Management of refractory anti-phospholipid syndrome","author":"Scoble","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.06.007","article-title":"Therapy of polymyositis and dermatomyositis","author":"Marie","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.05.011","article-title":"Autoimmune diseases of the peripheral nervous system","author":"Kieseier","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.04.024","article-title":"Refractory vasculitis","author":"Rutgers","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2010.06.012","article-title":"The CC homozygosis of the \u2212174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis","author":"Fabris","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2010.08.012","article-title":"The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus","volume":"10","author":"Galarza-Maldonado","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.autrev.2010.07.013","article-title":"Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: two sides of the same coin","volume":"9","author":"Conti","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0120","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1590-8658(07)80024-7","article-title":"Rituximab in mixed cryoglobulinemia: increased experience and perspectives","volume":"39","author":"De Vita","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-007-8019-0","article-title":"Rituximab as a therapeutic tool in severe mixed cryoglobulinemia","volume":"34","author":"Roccatello","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0130","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2007.081653","article-title":"Rituximab combined with Peg-interferon\u2013ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis","volume":"67","author":"Saadoun","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0135","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00415-009-5072-z","article-title":"Rituximab in cryoglobulinemic peripheral neuropathy","volume":"256","author":"Cavallo","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.07.005_bb0145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.07.005_bb0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.07.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.04.033","article-title":"A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection","author":"Visentini","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.07.005_bb0160","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/ard.2011.150755","article-title":"Preliminary classification criteria for the cryoglobulinaemic vasculitis","volume":"70","author":"De Vita","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinemia","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0170","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/acr.20318","article-title":"Safety and efficacy of rituximab in non-viral cryoglobulinemia vasculitis: data from the French AIR registry","volume":"62","author":"Terrier","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2011.07.005_bb0175","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.07.005_bb0180","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/ard.2002.004929","article-title":"Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis","volume":"62","author":"Lamprecht","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0185","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2011.07.005_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.20207","article-title":"Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstrom macroglobulinemia does not indicate failure of response","volume":"77","author":"Ghobrial","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0195","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1053\/j.ajkd.2003.12.057","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure","volume":"43","author":"Ghijsels","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0200","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/keh470","article-title":"Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia","volume":"44","author":"Catuogno","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.07.005_bb0205","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/01.tp.0000183749.79424.b4","article-title":"Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients","volume":"80","author":"Basse","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2011.07.005_bb0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ndt\/gfh564","article-title":"Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab","volume":"20","author":"Koukoulaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2011.07.005_bb0215","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","article-title":"Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids","volume":"45","author":"Quartuccio","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.07.005_bb0220","first-page":"1197","article-title":"Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab","volume":"33","author":"Cai","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/kel387","article-title":"Lack of efficacy of Rituximab in a patient with essential mixed cryoglobulinaemia","volume":"46","author":"Cohen","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2011.07.005_bb0230","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00296-007-0462-y","article-title":"Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab","volume":"28","author":"Braun","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.07.005_bb0235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1590\/S1413-86702007000100038","article-title":"The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia","volume":"11","author":"Rego","year":"2007","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0240","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2007.06.008","article-title":"Efficacy of low-dose rituximab for mixed cryoglobulinemia","volume":"125","author":"Visentini","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0245","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S1590-8658(07)80025-9","article-title":"Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab","volume":"39","author":"Petrarca","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0250","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/S1590-8658(07)80026-0","article-title":"Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report","volume":"39","author":"Massari","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0255","first-page":"27","article-title":"Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia","volume":"66","author":"Korte","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.autrev.2011.07.005_bb0260","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00296-009-1106-1","article-title":"Long-term efficacy of rituximab in hepatitis C virus-associated cryoglobulinemia","volume":"30","author":"da Silva Fucuta Pereira","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.07.005_bb0265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11239-008-0195-0","article-title":"A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab","volume":"27","author":"Pasa","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.autrev.2011.07.005_bb0270","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.4076\/1757-1626-2-7859","article-title":"Successful combination of Rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case report","volume":"2","author":"Tallarita","year":"2009","journal-title":"Cases J."},{"key":"10.1016\/j.autrev.2011.07.005_bb0275","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajh.21330","article-title":"Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab","volume":"84","author":"Ruch","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0280","first-page":"s84","article-title":"Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia","volume":"28","author":"Quartuccio","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0285","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-010-1412-8","article-title":"Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab","author":"Baerlecken","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0290","first-page":"196","article-title":"Clinical improvement induced by rituximab in two cases of type II mixed cryoglobulinaemia syndrome unresponsive to conventional treatments","volume":"8","author":"Cabibbo","year":"2010","journal-title":"Blood Transfus"},{"key":"10.1016\/j.autrev.2011.07.005_bb0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2009.10.006","article-title":"Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab","volume":"47","author":"Uppal","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0300","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10067-010-1612-2","article-title":"Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature","volume":"30","author":"Wink","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.07.005_bb0305","first-page":"S924","article-title":"A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (RTX) monotherapy versus the best available treatment in patients with mixed cryoglobulinemia syndrome","volume":"62","author":"De Vita","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.07.005_bb0310","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1002\/art.25000","article-title":"Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis","volume":"60","author":"S\u00e8ne","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.07.005_bb0315","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dld.2006.06.008","article-title":"Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T17:34:11Z","timestamp":1592760851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1568997211001686"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.07.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}